Paper66567
Long-term effects and after-effects of treatment of duodenal ulcer with metiamide.
Saunders JH and 1 other. Lancet, 1977. Cited by 58 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Long-term effects and after-effects of treatment of duodenal ulcer with metiamide. Papers, record 66567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/66567
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Duodenal Ulcer | Major topic |
| Histamine H2 Antagonists | Major topic |
| Clinical Trials as Topic | |
| Drug Administration Schedule | |
| Drug Evaluation | |
| Follow-Up Studies | |
| Humans | |
| Placebos | |
| Recurrence | |
| Remission, Spontaneous | |
| Time Factors |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,986,242 | Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/6986242 | PubMed |
| 6,786,895 | Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6786895 | PubMed |
| 1,685,465 | Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade. | Gut | 1991 | https://conductscience.org/library/papers/1685465 | PubMed |
| 647,322 | Cimetidine for ever (and ever and ever...)? | Br Med J | 1978 | https://conductscience.org/library/papers/647322 | PubMed |
| 630,311 | Relapse of duodenal ulceration after cimetidine treatment. | Br Med J | 1978 | https://conductscience.org/library/papers/630311 | PubMed |
| 603,851 | Current medical management of duodenal ulcer disease. | Can Med Assoc J | 1977 | https://conductscience.org/library/papers/603851 | PubMed |
| 394,490 | Cimetidine and the gastric surgeon. | World J Surg | 1979 | https://conductscience.org/library/papers/394490 | PubMed |
| 381,127 | Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects. | Gut | 1979 | https://conductscience.org/library/papers/381127 | PubMed |
| 372,063 | Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. | Gut | 1979 | https://conductscience.org/library/papers/372063 | PubMed |
| 99,391 | Role of cimetidine in relapse--prevention of duodenal ulcers healed by cimetidine. | Ir J Med Sci | 1978 | https://conductscience.org/library/papers/99391 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HRH2 | 3,274 | PubTator's text mining | https://conductscience.org/library/genes/3274 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/66567
GET https://conductscience.org/api/papers/v1/66567/authors